Ibsa Institut Biochimique Savia Al Ponte 13 Ch 6903lugano Ticino 6903 Pma Numberp110005 Supplement Numbers012 Date Received09 08 2022 Decision Date10 07 2022 Product Code Moz Advisory Committee Orthopedic Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Ibsa Institut Biochimique Savia Al Ponte 13 Ch 6903lugano Ticino 6903 Pma Numberp110005 Supplement Numbers012 Date Received09 08 2022 Decision Date10 07 2022 Product Code Moz Advisory Committee Orthopedic Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P110005S012 IBSA INSTITUT BIOCHIMIQUE SAvia Al Ponte 13, Ch-6903lugano Ticino 6903 PMA NumberP110005 Supplement NumberS012 Date Received09/08/2022 Decision Date10/07/2022 Product Code MOZ  Advisory Committee Orthopedic Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No	GELSYN-3	2022-10-07